Indicator Explainer
ASXL1 Gene
This gene may be involved in both transcriptional regulation and chromatin remodeling.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C97320. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-19. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — ASXL1 Gene (C97320)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C97320. NCI definition, reproduced without modification under CC BY 4.0.
- Splenomegaly in de novo acute myeloid leukemia is associated with ASXL1 mutations together with a distinct clinical and gene expression profile. — Biomark Res, 2025-10-22 (PMID 41126357; literature)
- Genetic profile of ASXL1 gene in risk assessment in acute myeloid leukemia. — BMC Genom Data, 2025-07-12 (PMID 40652162; literature)
- Impact of ASXL1 Gene Alterations on Myelodysplastic Syndrome With Isolated 20q Deletion. — Cancer Med, 2025-03-01 (PMID 40047093; literature)